Almirall, S.A./€ALM
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About Almirall, S.A.
Almirall, S.A. is a pharmaceutical company headquartered in Barcelona, Spain. It specializes in the development and commercialization of proprietary medicines, with a focus on dermatology and other specialist-driven therapeutic areas. Almirall's notable products target conditions such as psoriasis, atopic dermatitis, and actinic keratosis. Founded in 1943, the company has expanded its geographical footprint across Europe and North America through strategic acquisitions and partnerships. Almirall emphasizes research and development, maintaining a pipeline of innovative treatments aimed at unmet medical needs. Its strategic positioning is reinforced by collaborations with healthcare professionals and institutions to enhance patient care.
Ticker
€ALM
Sector
Primary listing
BME
Employees
2,097
Headquarters
Website
Almirall, S.A. Metrics
BasicAdvanced
€2.4bn
40.21
€0.28
0.18
€0.15
1.36%
Price and volume
Market cap
€2.4bn
Beta
0.18
52-week high
€13.98
52-week low
€10.06
Average daily volume
123k
Dividend rate
€0.15
Financial strength
Current ratio
2.308
Quick ratio
1.704
Long term debt to equity
22.536
Total debt to equity
23.763
Dividend payout ratio (TTM)
6.42%
Interest coverage (TTM)
5.57%
Profitability
EBITDA (TTM)
220.428
Gross margin (TTM)
77.04%
Net profit margin (TTM)
5.11%
Operating margin (TTM)
8.70%
Effective tax rate (TTM)
35.15%
Revenue per employee (TTM)
€550,000
Management effectiveness
Return on assets (TTM)
2.69%
Return on equity (TTM)
3.95%
Valuation
Price to earnings (TTM)
40.209
Price to revenue (TTM)
2.055
Price to book
1.58
Price to tangible book (TTM)
4.22
Price to free cash flow (TTM)
24.911
Free cash flow yield (TTM)
4.01%
Free cash flow per share (TTM)
0.446
Dividend yield (TTM)
1.36%
Growth
Revenue change (TTM)
9.76%
Earnings per share change (TTM)
179.01%
3-year revenue growth (CAGR)
8.79%
10-year revenue growth (CAGR)
4.53%
3-year earnings per share growth (CAGR)
73.31%
10-year earnings per share growth (CAGR)
-11.02%
3-year dividend per share growth (CAGR)
0.54%
10-year dividend per share growth (CAGR)
-0.16%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.